Abstract
Plasma levels of IL-1, IL-6, IL-8, IL1-RA, TNF alpha, and G-CSF were prospectively studied during 23 chemotherapy cycles of 20 patients suffering from acute myelogenous leukemia. Increased plasma levels of IL-6, IL-8, and G-CSF were observed in patients with febrile neutropenia and/or major infection. Plasma levels of IL-6, IL-1, TNF alpha and IL-1-RA measured 1 day before and 1 day after the onset of febrile episodes did not accurately predict the development of major infection. In contrast, IL-8 plasma levels were significantly higher in those patients who subsequently developed major infection. The question whether IL-8 plasma levels identify high risk or low risk patients with sufficient specificity and sensitivity has to be answered in large scale clinical trials.
MeSH terms
-
Adolescent
-
Adult
-
Animals
-
Antimetabolites, Antineoplastic / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Cytarabine / administration & dosage
-
Cytokines / blood*
-
Dacarbazine / administration & dosage
-
Female
-
Fever
-
Granulocyte Colony-Stimulating Factor / blood
-
Humans
-
Interleukin 1 Receptor Antagonist Protein
-
Interleukin-1 / antagonists & inhibitors
-
Interleukin-2 / blood
-
Interleukin-6 / blood
-
Interleukin-8 / blood
-
Leukemia, Myeloid, Acute / blood
-
Leukemia, Myeloid, Acute / complications
-
Leukemia, Myeloid, Acute / drug therapy*
-
Male
-
Middle Aged
-
Mitoxantrone / administration & dosage
-
Neutropenia / blood*
-
Neutropenia / etiology
-
Nimustine / administration & dosage
-
Prospective Studies
-
Sialoglycoproteins / blood
-
Tumor Necrosis Factor-alpha / analysis
-
Vincristine / administration & dosage
Substances
-
Antimetabolites, Antineoplastic
-
Cytokines
-
IL1RN protein, human
-
Interleukin 1 Receptor Antagonist Protein
-
Interleukin-1
-
Interleukin-2
-
Interleukin-6
-
Interleukin-8
-
Sialoglycoproteins
-
Tumor Necrosis Factor-alpha
-
Cytarabine
-
Nimustine
-
Granulocyte Colony-Stimulating Factor
-
Vincristine
-
Dacarbazine
-
Mitoxantrone
Supplementary concepts
-
DAV protocol
-
NOAC protocol